Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1971 Sep;43(1):242–247. doi: 10.1111/j.1476-5381.1971.tb07173.x

Comparison of human serum, parotid and mixed saliva levels of phenoxymethylpenicillin, ampicillin, cloxacillin and cephalexin

C F Speirs, D Stenhouse, K W Stephen, Edith T Wallace
PMCID: PMC1665947  PMID: 5002800

Abstract

1. A study has been made of serum, mixed and parotid salivary levels attained in normal volunteers following oral dosage of 500 mg phenoxymethylpenicillin tablets, 500 mg crushed phenoxymethylpenicillin tablets in capsules, 500 mg ampicillin, 500 mg cloxacillin and 500 mg cephalexin.

2. High mixed saliva levels were obtained with phenoxymethylpenicillin tablets and it is considered that these were due to rapid intra-oral dissolution of surface powder from friable tablets. No saliva levels were detected when tablets from the same batch were put into capsules.

3. Low or no saliva levels were achieved with ampicillin, cloxacillin and cephalexin.

4. The mode of action of antibiotics in oral infections is discussed.

Full text

PDF
242

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BENDER I. B., PRESSMAN R. S., TASHMAN S. G. Studies on excretion of antibiotics in human saliva. I. Penicillin and streptomycin. J Am Dent Assoc. 1953 Feb;46(2):164–170. doi: 10.14219/jada.archive.1953.0018. [DOI] [PubMed] [Google Scholar]
  2. BENDER I. B., PRESSMAN R. S., TASHMAN S. G. Studies on excretion of antibiotics in human saliva. II. Chloramphenicol. J Dent Res. 1953 Apr;32(2):287–293. doi: 10.1177/00220345530320021801. [DOI] [PubMed] [Google Scholar]
  3. BENDER I. B., PRESSMAN R. S., TASHMAN S. G. Studies on excretion of antibiotics in human saliva. III. Aureomycin. J Dent Res. 1953 Jun;32(3):435–439. doi: 10.1177/00220345530320031801. [DOI] [PubMed] [Google Scholar]
  4. KRIPPAEHNE W. W., HUNT T. K., DUNPHY J. E. Acute suppurative parotitis: a study of 161 cases. Ann Surg. 1962 Aug;156:251–257. doi: 10.1097/00000658-196208000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. MAY J. R., DELVES D. M. TREATMENT OF CHRONIC BRONCHITIS WITH AMPICILLIN: SOME PHARMACOLOGICAL OBSERVATION. Lancet. 1965 May 1;1(7392):929–933. doi: 10.1016/s0140-6736(65)91253-5. [DOI] [PubMed] [Google Scholar]
  6. Mason D. K., Harden R. M., Rowan D., Alexander W. D. Recording the pattern of salivary flow. J Dent Res. 1966 Sep-Oct;45(5):1458–1463. doi: 10.1177/00220345660450053301. [DOI] [PubMed] [Google Scholar]
  7. PELLERAT J. SUR L''ELIMINATION SALIVAIRE DE QUELQUES ANTIBIOTIQUES. Presse Med. 1963 Oct 26;71:2135–2136. [PubMed] [Google Scholar]
  8. SHANNON I. L. Parotid fluid flow rate as related to whole saliva volume. Arch Oral Biol. 1962 May-Jun;7:391–394. doi: 10.1016/0003-9969(62)90032-8. [DOI] [PubMed] [Google Scholar]
  9. Speirs C. F., Stephen K. W. Antibacterial drugs for oral infections. Br Dent J. 1968 Aug 20;125(4):158–162. [PubMed] [Google Scholar]
  10. Stewart S. M., Fisher M., Young J. E., Lutz W. Ampicillin levels in sputum, serum, and saliva. Thorax. 1970 May;25(3):304–311. doi: 10.1136/thx.25.3.304. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES